11-68929226-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002180.3(IGHMBP2):​c.1104C>T​(p.Tyr368Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00661 in 1,613,790 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0067 ( 74 hom. )

Consequence

IGHMBP2
NM_002180.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.44

Publications

6 publications found
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
IGHMBP2 Gene-Disease associations (from GenCC):
  • autosomal recessive distal spinal muscular atrophy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease axonal type 2S
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary peripheral neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 11-68929226-C-T is Benign according to our data. Variant chr11-68929226-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.44 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00546 (832/152304) while in subpopulation AMR AF = 0.00889 (136/15302). AF 95% confidence interval is 0.00767. There are 6 homozygotes in GnomAd4. There are 407 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGHMBP2NM_002180.3 linkc.1104C>T p.Tyr368Tyr synonymous_variant Exon 8 of 15 ENST00000255078.8 NP_002171.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078.8 linkc.1104C>T p.Tyr368Tyr synonymous_variant Exon 8 of 15 1 NM_002180.3 ENSP00000255078.4

Frequencies

GnomAD3 genomes
AF:
0.00541
AC:
823
AN:
152186
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00896
Gnomad ASJ
AF:
0.0132
Gnomad EAS
AF:
0.00328
Gnomad SAS
AF:
0.00746
Gnomad FIN
AF:
0.00235
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00714
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.00678
AC:
1702
AN:
251104
AF XY:
0.00715
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.00705
Gnomad ASJ exome
AF:
0.0187
Gnomad EAS exome
AF:
0.00337
Gnomad FIN exome
AF:
0.00295
Gnomad NFE exome
AF:
0.00763
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.00672
AC:
9828
AN:
1461486
Hom.:
74
Cov.:
32
AF XY:
0.00681
AC XY:
4952
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33480
American (AMR)
AF:
0.00689
AC:
308
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
475
AN:
26136
East Asian (EAS)
AF:
0.00229
AC:
91
AN:
39698
South Asian (SAS)
AF:
0.00679
AC:
586
AN:
86258
European-Finnish (FIN)
AF:
0.00277
AC:
147
AN:
53030
Middle Eastern (MID)
AF:
0.0267
AC:
154
AN:
5766
European-Non Finnish (NFE)
AF:
0.00679
AC:
7550
AN:
1112004
Other (OTH)
AF:
0.00810
AC:
489
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
576
1152
1728
2304
2880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00546
AC:
832
AN:
152304
Hom.:
6
Cov.:
32
AF XY:
0.00547
AC XY:
407
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00132
AC:
55
AN:
41566
American (AMR)
AF:
0.00889
AC:
136
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0132
AC:
46
AN:
3472
East Asian (EAS)
AF:
0.00328
AC:
17
AN:
5178
South Asian (SAS)
AF:
0.00746
AC:
36
AN:
4824
European-Finnish (FIN)
AF:
0.00235
AC:
25
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00717
AC:
488
AN:
68026
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00659
Hom.:
7
Bravo
AF:
0.00550
Asia WGS
AF:
0.0130
AC:
44
AN:
3478
EpiCase
AF:
0.00900
EpiControl
AF:
0.00966

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IGHMBP2: BP4, BS2 -

not specified Benign:2
Nov 14, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Autosomal recessive distal spinal muscular atrophy 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
2.4
DANN
Benign
0.43
PhyloP100
3.4
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148157556; hg19: chr11-68696694; API